Summary on Adverse Reactions of Antidiabetic Drugs

Abstract

Abstract: Objective To provide a basis for rational drug use in clinic by reviewing clinical adverse reactions caused by all kinds of antidiabetic drugs. Methods The related references in recent years at home and abroad about clinical adverse reactions of antidiabetic drugs were collected, summarized and analyzed. Results In the process of diabetic treatment, it could cause a lot of adverse reactions along with the drug dose increased and other factors affected, and at present the commonly clinical adverse reactions of antidiabetic drug were mainly hypoglycemia, gastrointestinal symptoms, allergy reaction, metabolism and nutrition disorder, and so on. Conclusion The adverse reactions of antidiabetic drugs involved many systems, even resulted in some serious consequences, so clinical doctors should pay more attention to the adverse reactions of antidiabetic drugs, strengthen rational drug use in clinic, enhance the treatment effect, and reduce the pain of patients.

Key words: diabetes, therapeutic drugs, clinical adverse reaction

CLC Number:

SHI Hong-bo, CAI Qiang. Summary on Adverse Reactions of Antidiabetic Drugs [J]. Chinese Journal of Pharmacovigilance, 2013, 10(3): 159-162.

References

[1] 胡楠,张轶.抗糖尿病药物应用情况分析与使用中应注意的问题[J].中国临床医生,2007,35(11) :65-66.
[2] James X Z.Complexity of drug therapy and its implications for quality of diabetes care[J].World J Diabetes,2011,2(7) :105-107.
[3] 王艳梅.格列美脲治疗2 型糖尿病50 例分析[J].中国误诊学杂志,2008,8(9)：2178-2179.
[4] 杨玲.格列美脲与格列吡嗪治疗初诊超重的2 型糖尿病疗效比较[J].江苏大学学报(医疗版),2005,15(6)：491-493.
[5] 汤文璐,王永铭,杜文民,等.国内42 年文献源抗糖尿病药物的不良反应分析[J].中国新药与临床杂志,2002,21(12) :753-756.
[6] 区炳雄,肖焕.常用口服降糖药的适应证、不良反应和禁忌证[J].现代食品与药品杂志,2006,16(3) :100-102.
[7] 汤文璐.上海市老年人群抗糖尿病药物的药物流行病学研究[D].上海: 复旦大学,2003.
[8] 李轶.糖尿病患者的口服降糖药的分析[J].医学信息,2011(2) : 404.
[9] 李洪梅.α-葡萄糖苷酶抑制剂的临床应用[J].中国医刊,2007,42(10) :19-21.
[10] 苏杰英,李宏亮,杨文英.强化降糖,任重道远[J].中国糖尿病杂志,2008,16( 12) :761-762.
[11] 赵锦欢.五类口服降糖药你选对了吗[J].医药与保健,2009(7) :19-21.
[12] 王春玲.糖尿病患者低血糖的发病因素及其防治[J].实用糖尿病杂志,2008,4(5) :60.
[13] 陆祖谦. 双胍类降糖药物对2 型糖尿病治疗价值的重新认识[J].临床药物治疗杂志,2010,8(4) :33-38.
[14] 裴振峨.罗格列酮与心脏的安全风险[J].临床药物治疗杂志,2007,5(4) :32-35.
[15] 朱秀娟,许道农.二甲双胍诱发乙肝患者肝功能损害一例[J].药物流行病学杂志,2010,19(3) :163.
[16] 李彩萍,张乌云.从IDF看阿卡波糖的应用与评价[J].实用糖尿病杂志,2008,16(4):4-5.
[17] 汤文璐,王永铭,杜文民,等.国内42 年文献源抗糖尿病药物的不良反应分析[J].中国新药与临床杂志,2002,21(12) : 756-758.
[18] 郑诗峰.口服降糖药的作用机制及临床应用进展[J].社区医学杂志,2011,9(1):19-22.
[19] 王春玲.糖尿病患者低血糖的发病因素及其防治[J].实用糖尿病杂志,2008,4(5) :60.
[20] 计成,张海霞.口服阿卡波糖片致心律失常一例[J].药物流行病学杂志,2010,19(5) :266.
[21] 元鲁光,刘清,王娟. 阿卡波糖致全身严重性皮疹一例[J].中国新药杂志,2005,14(1) :53.
[22] Denker P S,Dimarco P E.Exenatide(exendin-4) induced pancreatitis:a case report[J].Diabetes Care,2006,29(2):471.
[23] 王春玲.糖尿病患者低血糖的发病因素及其防治[J].实用糖尿病杂志,2008,4(5):60.
[24] 崔瑞洁.糖尿病患者药物应用及不良反应分析[J].中国实用医药,2010,5(33) :188-189.
[25] Zinman B,Hoogwerf B J,Duran Garcia S,et al.The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial[J].Ann Intern Med,2007,146(7) : 477-485.
[26] 鲁郡,顾明居.噻唑烷二酮类药物与骨质疏松[J].临床荟萃,2011,26(1) :79-82.
[27] 佚名.美国FDA 警告吡格列酮引起的膀胱癌风险[J].中国执业药师,2011,18( 2) :20-22.
[28] Williams Herman D,Round E,Swern A S,et al.Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis[J].BMC Endocr Disord,2008,27(8) :14.
[29] 郑芙林.糖尿病药物治疗及机制研究进展[J].中国基层医药,2008,15 (12) : 2071-2072.
[30] 胡楠,张轶.抗糖尿病药物应用情况分析与使用中应注意的问题[J].中国临床医生,2007,35(11) :65-66.
[31] 刘亚萍.糖尿病药物的不良反应分析[J].现代医药卫生,2008,24(19) :2982-2983.
[32] 李巍.老年糖尿病患者用药治疗应注意的问题[J].中国实用医药,2010,5(13) :157-158.
[33] 杜丽荣.多种胰岛素制剂过敏一例[J].临床误诊误治,2008,21(5) ：98.
[34] 邓广宁,李东明,王东济,等.多种胰岛素制剂过敏反应8 例临床分析[J]. 临床荟萃,2011,26(6) : 522.
[35] 陈上云,劳干诚.药物性低血糖症37 例诊治体会[J].中国实用内科杂志,1999,19(4) :230-231.
[36] 陈园胜.消渴丸治疗老年2型糖尿病致低血糖发生的原因分析[J].航空航天医学杂志,2011,22(4) :400,402.
[37] 曲毅,张力.消渴丸致严重低血糖反应36 例文献分析[J].中国药物警戒,2009,6(2) :99-101.